Technology
The FDA claims the wearable tech company's BPI offering is "adulterated" and "misbranded," and is being sold without the proper regulatory approvals.
Artificial intelligence gives Cedars-Sinai's clinicians EHR-supported diagnoses and treatment plan recommendations after patients complete virtual urgent care clinic intake questions in a structured chat.
Hippocratic AI will integrate its generative AI agents to support triage and patient intake.
Arnaub Chatterjee, Datavant president and GM of life sciences, says the company will streamline data linking and evidence generation across real-world and clinical trial data.
The news comes alongside the U.S. Department of Defense’s announcement of $200 million contracts awarded to xAI, Anthropic, Google and OpenAI for AI implementation.
AI and synthetic-driven research can help clinicians gain a patient's trust, according to Adrienne Boissy, Qualtrics CMO.
The AI co-developed with ASX-listed Artrya can outperform the Agatston score in predicting cardiac events.
It can also predict the onset of Parkinson's motor symptoms.
Developing an AI platform internally can be more cost-effective and manageable, said Ryan Sadeghian, chief medical information officer at the University of Toledo, at HIMSS AI Forum.
Plaintiffs allege that CRISP and its subsidiary willfully infringed on patented technology by launching a copycat product after terminating a long-standing licensing agreement.